|
1) Vousden KH, Ryan KM. p53 and metabolism. Nat Rev Cancer. 2009; 9: 691-700
|
|
|
|
2) Gaulton KJ, Willer CJ, Li Y, et al. Comprehensive association study of type 2 diabetes and related quantitative traits with 222 candidate genes. Diabetes. 2008; 57: 3136-44
|
|
|
|
|
3) Gloria-Bottini F, Banci M, Saccucci P, et al. Is there a role of p53 codon 72 polymorphism in the susceptibility to type 2 diabetes in overweight subjects？ A study in patients with cardiovascular diseases. Diabetes Res Clin Pract. 2011; 91: e64-7
|
|
|
|
|
|
4) Kojima S, Iwai N, Tago N, et al. 53Arg72Pro polymorphism of tumour suppressor protein is associated with luminal narrowing after coronary stent placement. Heart. 2004; 90: 1069-70
|
|
|
|
|
|
5) Yahagi N, Shimano H, Matsuzaka T, et al. p53 Activation in adipocytes of obese mice. J Biol Chem. 2003; 278: 25395-400
|
|
|
|
|
|
6) Stambolic V, MacPherson D, Sas D, et al. Regulation of PTEN transcription by p53. Mol Cell. 2001; 8: 317-25
|
|
|
|
|
|
7) Minamino T, Orimo M, Shimizu I, et al. A crucial role for adipose tissue p53 in the regulation of insulin resistance. Nat Med. 2009; 15: 1082-7
|
|
|
|
|
|
8) Medes G, Thomas A, Weinhouse S. Metabolism of neoplastic tissue. IV. A study of lipid synthesis in neoplastic tissue slices in vitro. Cancer Res. 1953; 13: 27-9
|
|
|
|
|
|
9) DʼErchia AM, Tullo A, Lefkimmiatis K, et al. The fatty acid synthase gene is a conserved p53 family target from worm to human. Cell Cycle. 2006; 5: 750-8
|
|
|
|
|
|
10) Buzzai M, Jones RG, Amaravadi RK, et al. Systemic treatment with the antidiabetic drug metformin selectively impairs p53-deficient tumor cell growth. Cancer Res. 2007; 67: 6745-52
|
|
|
|
|
|
11) Long JS, Edwards J, Watson C, et al. Sphingosine kinase 1 induces tolerance to human epidermal growth factor receptor 2 and prevents formation of a migratory phenotype in response to sphingosine 1-phosphate in estrogen receptor-positive breast cancer cells. Mol Cell Biol. 2010; 30: 3827-41
|
|
|
|
|
|
12) Watson C, Long JS, Orange C, et al. High expression of sphingosine 1-phosphate receptors, S1P1 and S1P3, sphingosine kinase 1, and extracellular signal-regulated kinase-1/2 is associated with development of tamoxifen resistance in estrogen receptor-positive breast cancer patients. Am J Pathol. 2010; 177: 2205-15
|
|
|
|
|
|
13) Heffernan-Stroud LA, Helke KL, Jenkins RW, et al. Defining a role for sphingosine kinase 1 in p53-dependent tumors. Oncogene. 2011 Jul 18. [Epub ahead of print]
|
|
|
|
|
|
14) Panjarian S, Kozhaya L, Arayssi S, et al. De novo N-palmitoylsphingosine synthesis is the major biochemical mechanism of ceramide accumulation following p53 up-regulation. Prostaglandins Other Lipid Mediat. 2008; 86: 41-8
|
|
|
|
|
|
15) Schwartzenberg-Bar-Yoseph F, Armoni M, Karnieli E. The tumor suppressor p53 down-regulates glucose transporters GLUT1 and GLUT4 gene expression. Cancer Res. 2004; 64: 2627-33
|
|
|
|
|
|
16) Bensaad K, Tsuruta A, Selak MA, et al. TIGAR, a p53-inducible regulator of glycolysis and apoptosis. Cell. 2006; 126: 107-20
|
|
|
|
|
|
17) Matoba S, Kang JG, Patino WD, et al. p53 regulates mitochondrial respiration. Science. 2006; 312: 1650-3
|
|
|
|
|
|
18) Jones RG, Plas DR, Kubek S, et al. AMP-activated protein kinase induces a p53-dependent metabolic checkpoint. Mol Cell. 2005; 18: 283-93
|
|
|
|
|
|
19) Vousden KH. Alternative fuel-another role for p53 in the regulation of metabolism. Proc Natl Acad Sci U S A. 2010; 107: 7117-8
|
|
|
|
|
|
20) Suzuki S, Tanaka T, Poyurovsky MV, et al. Phosphate-activated glutaminase (GLS2), a p53-inducible regulator of glutamine metabolism and reactive oxygen species. Proc Natl Acad Sci U S A. 2010; 107: 7461-6
|
|
|
|
|
|
21) Polyak K, Xia Y, Zweier JL, et al. A model for p53-induced apoptosis. Nature. 1997; 389: 300-5
|
|
|
|
|
|
22) Rivera A, Maxwell SA. The p53-induced gene-6 (proline oxidase) mediates apoptosis through a calcineurin-dependent pathway. J Biol Chem. 2005; 280: 29346-54
|
|
|
|
|
|
23) Liu Z, Lu H, Shi H, et al. PUMA overexpression induces reactive oxygen species generation and proteasome-mediated stathmin degradation in colorectal cancer cells. Cancer Res. 2005; 65: 1647-54
|
|
|
|
|
|
24) Trinei M, Giorgio M, Cicalese A, et al. A p53-p66Shc signalling pathway controls intracellular redox status, levels of oxidation-damaged DNA and oxidative stress-induced apoptosis. Oncogene. 2002; 21: 3872-8
|
|
|
|
|
|
25) Budanov AV, Karin M. p53 target genes sestrin1 and sestrin2 connect genotoxic stress and mTOR signaling. Cell. 2008; 134: 451-60
|
|
|
|
|
|
26) Jiang P, Du W, Wang X, et al. p53 regulates biosynthesis through direct inactivation of glucose-6-phosphate dehydrogenase. Nat Cell Biol. 2011; 13: 310-6
|
|
|
|
|